StatusFinished
Effective start/end date7/1/086/30/09

Funding

  • Arizona Alzheimer's Consortium: $156,275.00

Fingerprint

Transgenic Mice
Immunoglobulins
Alzheimer Disease
Apolipoprotein E4
Organized Financing
Nervous System Diseases
Serum
Immunotherapy
Communicable Diseases
Prospective Studies
Technology
Peptides
Mutation
Health
Pharmaceutical Preparations
Therapeutics
caN protocol